ATE241985T1 - Therapeutisches mittel zur behandlung von nierenerkrankungen - Google Patents
Therapeutisches mittel zur behandlung von nierenerkrankungenInfo
- Publication number
- ATE241985T1 ATE241985T1 AT97904570T AT97904570T ATE241985T1 AT E241985 T1 ATE241985 T1 AT E241985T1 AT 97904570 T AT97904570 T AT 97904570T AT 97904570 T AT97904570 T AT 97904570T AT E241985 T1 ATE241985 T1 AT E241985T1
- Authority
- AT
- Austria
- Prior art keywords
- lower alkyl
- therapeutic agent
- different
- same
- treatment
- Prior art date
Links
- 239000003814 drug Substances 0.000 title abstract 3
- 208000017169 kidney disease Diseases 0.000 title abstract 3
- 229940124597 therapeutic agent Drugs 0.000 title abstract 3
- 125000000217 alkyl group Chemical group 0.000 abstract 5
- 239000001257 hydrogen Substances 0.000 abstract 5
- 229910052739 hydrogen Inorganic materials 0.000 abstract 5
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 5
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 2
- 208000007342 Diabetic Nephropathies Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 125000004423 acyloxy group Chemical group 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000002102 aryl alkyloxo group Chemical group 0.000 abstract 1
- 125000001589 carboacyl group Chemical group 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 208000033679 diabetic kidney disease Diseases 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- -1 methylenedioxy Chemical group 0.000 abstract 1
- 201000008383 nephritis Diseases 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 125000002294 quinazolinyl group Chemical class N1=C(N=CC2=CC=CC=C12)* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/541—Non-condensed thiazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP3041196 | 1996-02-19 | ||
| PCT/JP1997/000439 WO1997029749A1 (en) | 1996-02-19 | 1997-02-19 | Therapeutic agent for kidney diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE241985T1 true ATE241985T1 (de) | 2003-06-15 |
Family
ID=12303214
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97904570T ATE241985T1 (de) | 1996-02-19 | 1997-02-19 | Therapeutisches mittel zur behandlung von nierenerkrankungen |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP0919233B8 (de) |
| AT (1) | ATE241985T1 (de) |
| AU (1) | AU1732697A (de) |
| CA (1) | CA2245896C (de) |
| DE (1) | DE69722630T2 (de) |
| WO (1) | WO1997029749A1 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014102592A2 (en) | 2012-12-27 | 2014-07-03 | Purdue Pharma L.P. | Oxime/substituted quinoxaline-type piperidine compounds and uses thereof |
| US9771351B2 (en) * | 2013-07-29 | 2017-09-26 | Kyowa Hakko Kirin Co., Ltd. | Wnt signaling inhibitor |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2118117A1 (en) * | 1993-02-18 | 1994-08-19 | Shigeki Fujiwara | Adenosine uptake inhibitor |
| JPH09165385A (ja) * | 1994-08-26 | 1997-06-24 | Kyowa Hakko Kogyo Co Ltd | キナゾリン誘導体 |
-
1997
- 1997-02-19 EP EP97904570A patent/EP0919233B8/de not_active Expired - Lifetime
- 1997-02-19 AU AU17326/97A patent/AU1732697A/en not_active Abandoned
- 1997-02-19 DE DE69722630T patent/DE69722630T2/de not_active Expired - Fee Related
- 1997-02-19 CA CA002245896A patent/CA2245896C/en not_active Expired - Fee Related
- 1997-02-19 WO PCT/JP1997/000439 patent/WO1997029749A1/ja not_active Ceased
- 1997-02-19 AT AT97904570T patent/ATE241985T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0919233A1 (de) | 1999-06-02 |
| EP0919233A4 (de) | 2000-05-10 |
| AU1732697A (en) | 1997-09-02 |
| DE69722630D1 (de) | 2003-07-10 |
| EP0919233B8 (de) | 2003-08-13 |
| WO1997029749A1 (en) | 1997-08-21 |
| CA2245896C (en) | 2003-06-10 |
| DE69722630T2 (de) | 2004-04-29 |
| CA2245896A1 (en) | 1997-08-21 |
| EP0919233B1 (de) | 2003-06-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HU9600834D0 (en) | Quinazoline derivatives | |
| ATE247654T1 (de) | Neue heterozyklische verbindungen | |
| SE9604786D0 (sv) | New compounds | |
| NZ337118A (en) | 3-piperidyl-4-oxoquinazoline derivatives and pharmaceutical compositions comprising the same useful in treating or preventing arteriosclerotic and/or hyper-lipemia disease, pancreatitis, obesity, hypercholesterolemia and hypertriglyceridemia. | |
| DE69519469D1 (de) | Chinazolin-derivate | |
| MX9202844A (es) | 1-indolilalquil-4-( alcoxi-pirimidinil) piperazinas y composicion farmaceutica que las contiene. | |
| ATE318799T1 (de) | Pyrrolderivate und medizinische zubereitung. | |
| EP0640601A4 (de) | Benzamid-derivate. | |
| DE69935718D1 (de) | Antidiabetische medikamente | |
| DE69501359D1 (de) | Verwendung von Phosphatdiestern zur Behandlung von Erkrankungen der Retina | |
| DE69500673D1 (de) | Arzneimittel zur therapeutischen und prophylaktischen Behandlung von Krankheiten, die durch Hyperplasie der glatten Muskelzellen bedingt sind | |
| DE69828197D1 (de) | Amidderivate zur behandlung neurodegenerativer erkrankungen der netzhaut | |
| DE69017855D1 (de) | Oxetan-Derivate, ihre Herstellung und ihre Verwendung als Anti-Fungal oder fungizides Mittel. | |
| DE69722630D1 (de) | Therapeutisches mittel zur behandlung von nierenerkrankungen | |
| ATE86117T1 (de) | Zusammensetzung gegen leberkrankheiten. | |
| ATE186912T1 (de) | Carbamoylpyrrolidon-derivate zur behandlung von depressionen und cerebrovasculären störungen | |
| ATE212842T1 (de) | Quinoxalin-derivate zur behandlung von tinnitus | |
| DE69219219D1 (de) | Verwendung von 3-Pyridazinone zur Verringerung der Blutplätchenzahl | |
| DE69827706D1 (de) | 5-(Heteroaryl)alkyl)-3-oxo-pyrido(1,2-a)benzimidazol-4-carboxamid (PBI) Derivate zur Behandlung von Störungen des zentralen Nervensystems | |
| ATE314339T1 (de) | Polyhydroxyphenolderivate und mittel zur vorbeugung und therapie von knochen- und knorpelkrankheiten die diese enthalten | |
| DE69914563D1 (de) | Azaindol derivate und ihre Verwendung als antithrombotische Wirkstoffe | |
| DE3782229D1 (de) | Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten. | |
| DE69424677D1 (de) | Präparat zur behandlung der drogenabhängigkeit |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |